Journal Scans
Positron Emission Tomography/Computed Tomography in the Management of Recurrent/Metastatic Breast Cancer: A Large Retrospective Study From the Royal Marsden Hospital
PET/CT in Management of Breast Cancer
A Constantinidou, A Martin, B Sharma, SRD Johnston
20100612
2010 Jul 12
Ann Oncol
Positron Emission Tomography/Computed Tomography in the Management of Recurrent/Metastatic Breast Cancer: A Large Retrospective Study From the Royal Marsden Hospital
Ann Oncol. 2010 Jul 12;[Epub Ahead of Print], A Constantinidou, A Martin, B Sharma, SRD Johnston
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
The role of positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in breast cancer has not been clearly defined. The technique is not reliable in evaluating the primary tumor or in staging axillary disease, because of its low accuracy and high number of false-negative results. However, in small retrospective studies, PET and PET combined with computed tomography (CT) scanning have shown high sensitivity and specificity in assessing metastatic disease, including small...
